| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.097 | 0.2 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.2 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |